This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 964220.

To develop AI-based diagnostics tools that could be used by healthcare professionals in the future, the AI-Mind team search for the best ways to increase the impact of the project results and facilitate their uptake with the benefit to the patients. Committed to that, Lurtis, on behalf of all small and medium-sized enterprises (SME) involved in the AI-Mind, successfully applied for the Horizon IP Scan service offered by European Commission. Now all AI-Mind SMEs partners, namely BrainSymph, Neuroconnect and accelopment will use the opportunity to discuss with a dedicated expert the scope and implementation steps of the service tailored to the specific requirements of the AI-Mind project.

To ensure smooth cooperation and maximise the impact of the project results, Intellectual Property (IP) needs to be managed and used strategically. The Horizon IP Scan, launched in March 2021 is designed to support start-ups and SMEs in EU-funded research to manage and valorise IP. In the frame of this agreement, AI-Mind SMEs partners will discuss the business model and market access routes with the IP management expert in the following months. As an outcome, SMEs involved will benefit from the report and recommendations provided by the Horizon IP Scan expert. The service will not only help to strengthen a joint IP management and exploitation strategy for the AI-Mind partners but shall boost our Plan for the Exploitation and Dissemination of Results.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *